Ahmed Amany H, Shankar Kj, Eftekhari Hossein, Munir Ms, Robertson Jillian, Brewer Alan, Stupin Igor V, Casscells S Ward
Texas Heart Institute at St Luke's Episcopal Hospital, Houston, Texas;
Exp Clin Cardiol. 2007 Winter;12(4):189-96.
Silent myocardial ischemia (SMI) is increasingly being recognized as part of the spectrum of ischemic heart disease. The spectrum of SMI ranges from asymptomatic coronary artery disease to critical illness necessitating intensive care. Although many diagnostic tools have been used to identify low- and high-risk subgroups, their use is limited by modest sensitivities and specificities. The present review identifies current concepts in the management of SMI in various clinical settings, as well as emerging technologies that may simplify the diagnosis and treatment of this condition.
无症状心肌缺血(SMI)日益被视为缺血性心脏病范畴的一部分。SMI 的范围从无症状冠状动脉疾病到需要重症监护的危重病。尽管已使用许多诊断工具来识别低风险和高风险亚组,但其应用受到敏感性和特异性一般的限制。本综述确定了在各种临床环境中管理 SMI 的当前概念,以及可能简化这种疾病诊断和治疗的新兴技术。